In addition, the clinic is equipped to care for migraines, dehydration, stomach issues, minor injuries, and other urgent health concerns
Document your weight history, including your weight at various points in your life, highest and lowest adult weights, and any significant weight fluctuations
Clinical trial data from the SURMOUNT series shows these incidence rates: Nausea: approximately 20 percent of patients Diarrhea: approximately 16 percent of patients Vomiting: approximately 9 percent of patients Constipation: varies by dose level Decreased appetite: expected therapeutic effect Abdominal pain: less common but reported Most gastrointestinal side effects are mild to moderate and occur during the first few weeks of treatment or after dose increases
47 Visceral fat accumulation in patients with obesity causes a number of changes (oxidative stress, activation of the RAAS and gut dysbiosis), resulting in insulin resistance, increased vascular stiffness, T2D, dyslipidaemia, hypertension, coronary atherosclerosis and, ultimately, HFpEF
L-glutamine ameliorates the oxidative stress in sickle erythrocytes and reduces VOC
A normal lab panel does not prove growth-pathway exposure is risk-free